These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3126033)

  • 21. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade.
    Stern N; Golub M; Nozawa K; Berger M; Knoll E; Yanagawa N; Natarajan R; Nadler JL; Tuck ML
    Am J Physiol; 1989 Aug; 257(2 Pt 2):H434-43. PubMed ID: 2504056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of mononuclear leukocyte accumulation by the arachidonic acid lipoxygenase inhibitor BW755C.
    Higgs GA; Mugridge KG
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():19-23. PubMed ID: 6221592
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of arachidonic acid metabolism in IL-3-induced proliferation.
    Barton BE; WoldeMussie E; Wheeler L
    Immunopharmacol Immunotoxicol; 1988; 10(1):35-52. PubMed ID: 3129485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diacylglycerol provides arachidonic acid for lipoxygenase products that mediate angiotensin II-induced aldosterone synthesis.
    Natarajan R; Stern N; Nadler J
    Biochem Biophys Res Commun; 1988 Oct; 156(2):717-24. PubMed ID: 2847716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple procedure for measuring the pharmacodynamics and analgesic potential of lipoxygenase inhibitors.
    Carey F; Haworth D; Edmonds AE; Forder RA
    J Pharmacol Methods; 1988 Dec; 20(4):347-56. PubMed ID: 3145369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
    Nyby MD; Sasaki M; Ideguchi Y; Wynne HE; Hori MT; Berger ME; Golub MS; Brickman AS; Tuck ML
    J Pharmacol Exp Ther; 1996 Aug; 278(2):503-9. PubMed ID: 8768697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of inhibitors of arachidonic acid metabolism on erythropoiesis.
    Beckman B; Nystuen L
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jan; 31(1):23-6. PubMed ID: 3131779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key role of diacylglycerol-mediated 12-lipoxygenase product formation in angiotensin II-induced aldosterone synthesis.
    Natarajan R; Dunn WD; Stern N; Nadler J
    Mol Cell Endocrinol; 1990 Aug; 72(2):73-80. PubMed ID: 2178102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-derived growth factor is a potent inhibitor of angiotensin II-induced aldosterone synthesis.
    Natarajan R; Nadler J
    Mol Cell Endocrinol; 1992 Jan; 83(1):57-63. PubMed ID: 1312960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.
    Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD
    J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of transformation of 15(S)-hydroperoxyeicosatetraenoic acid to 15-series leukotrienes by purified porcine leukocyte 12-lipoxygenase.
    Brash AR; Oates JA; Yokoyama C; Yamamoto S
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():75-7. PubMed ID: 2821770
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin II-induced aldosterone synthesis is potentiated by epidermal growth factor.
    Natarajan R; Nadler J
    Endocrinology; 1991 May; 128(5):2285-90. PubMed ID: 1850348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoxygenase inhibitors reduce insulin secretion without impairing calcium mobilization.
    Metz SA
    Endocrinology; 1987 Jun; 120(6):2534-46. PubMed ID: 3106021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of arachidonic acid-induced ear edema in the mouse with lipoxygenase-, cyclo-oxygenase- and dual inhibitors].
    Zarnack S; Bekemeier H; Giessler AJ
    Pharmazie; 1988 May; 43(5):337-8. PubMed ID: 3140256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory properties of lipoxygenase products and the effects of indomethacin and BW755C on prostaglandin production, leukocyte migration, and plasma exudation in rabbit skin.
    Higgs GA; Bax CM; Moncada S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():331-9. PubMed ID: 6211959
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective inhibition of the lipoxygenase metabolic pathway of arachidonic acid by the SRS-A antagonist, FPL 55712.
    Casey FB; Appleby BJ; Buck DC
    Prostaglandins; 1983 Jan; 25(1):1-11. PubMed ID: 6405452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-derived growth factor BB mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells.
    Natarajan R; Bai W; Rangarajan V; Gonzales N; Gu JL; Lanting L; Nadler JL
    J Cell Physiol; 1996 Nov; 169(2):391-400. PubMed ID: 8908207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of lipoxygenation in human natural killer cell activation.
    Bray RA; Brahmi Z
    J Immunol; 1986 Mar; 136(5):1783-90. PubMed ID: 3081633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
    Carlson RP; O'Neill-Davis L; Chang J; Lewis AJ
    Agents Actions; 1985 Dec; 17(2):197-204. PubMed ID: 3938181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Hydroxyeicosatetraenoic acid increases prolactin release from rat anterior pituitary cells.
    Koike K; Judd AM; MacLeod RM
    Endocrinology; 1985 May; 116(5):1813-7. PubMed ID: 3921344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.